NSSI: Treatment Study for Non-Suicidal Self-Injury

Sponsor
Boston University Charles River Campus (Other)
Overall Status
Completed
CT.gov ID
NCT02060448
Collaborator
National Institute of Mental Health (NIMH) (NIH)
13
1
4
25
0.5

Study Details

Study Description

Brief Summary

The overall aim of this study is to begin establishing an effective treatment for individuals who engage in non-suicidal self-injury (NSSI), as there are currently no evidence-based treatments that directly target this problematic behavior. Existing treatments that have demonstrated initial promise in reducing NSSI consist of many skills embedded in complex programs; therefore, the skill(s) responsible for improvements in NSSI are not clear. Procedures that focus on one's emotions, particularly that aim to increase emotional awareness and engagement in cognitive reappraisal (i.e., a way of thinking that lessens emotions), may be critical in effective NSSI treatment. The specific goals of this study are to investigate the effects of two specific emotion-focused treatment elements on NSSI. Participants will be ten individuals who meet the proposed Diagnostic and Statistical Manual for Mental Disorders, 5th edition (DSM-5; American Psychiatric Association) criteria for NSSI disorder and engage in NSSI to reduce or escape from negative emotions. Two core modules of the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders (UP; Barlow et al., 2011) will be adapted and delivered with the aim of reducing participants' non-suicidal self-injurious thoughts and behaviors. Each treatment module will consist of four 50-minute individual weekly sessions of emotion awareness training or cognitive reappraisal. The study will use a single-case experimental design, and phase change will be determined based on each participant's changes in non-suicidal self-injurious thoughts and behaviors.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Emotion awareness training
  • Behavioral: Cognitive reappraisal
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
13 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Exploring Two Emotion-Focused Treatment Modules in Non-Suicidal Self-Injury
Study Start Date :
Nov 1, 2013
Actual Primary Completion Date :
Dec 1, 2015
Actual Study Completion Date :
Dec 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: 2wk baseline + awareness (+ reappraisal)

Participants in this arm will first undergo a two-week baseline phase. Participants who evidence a significant decrease in non-suicidal self-injurious thoughts and behaviors, or SITBs, (i.e., "responders") after emotion awareness training will go straight to a four-week follow-up, and not receive cognitive reappraisal. Participants who evidence a less than satisfactory response in non-suicidal SITBs (i.e., "partial responders") after emotion awareness training will return to a two-week baseline phase before receiving cognitive reappraisal, and then enter a four-week follow-up. Participants who evidence little to no response in non-suicidal SITBs (i.e., "non-responders") after emotion awareness training will immediately receive cognitive reappraisal and then enter a four-week follow-up.

Behavioral: Emotion awareness training
Four weekly individual treatment sessions focused on increasing awareness of one's emotions.

Behavioral: Cognitive reappraisal
Four weekly individual treatment sessions focused on thinking about stimuli in a way that diminishes one's emotions.

Experimental: 2wk baseline + reappraisal (+ awareness)

Participants will first undergo a two-week baseline phase. Participants who evidence a significant decrease in non-suicidal SITBs (i.e., "responders") after cognitive reappraisal will go straight to a four-week follow-up, and not receive emotion awareness training. Participants who evidence a less than satisfactory response in non-suicidal SITBs (i.e., "partial responders") after cognitive reappraisal will return to a two-week baseline phase before receiving emotion awareness training, and then enter a four-week follow-up. Participants who evidence little to no response in non-suicidal SITBs and behaviors (i.e., "non-responders") after cognitive reappraisal will immediately receive emotion awareness training and then enter a four-week follow-up.

Behavioral: Emotion awareness training
Four weekly individual treatment sessions focused on increasing awareness of one's emotions.

Behavioral: Cognitive reappraisal
Four weekly individual treatment sessions focused on thinking about stimuli in a way that diminishes one's emotions.

Experimental: 4wk baseline + awareness (+ reappraisal)

Participants in this arm will first undergo a four-week baseline phase. Participants who evidence a significant decrease in non-suicidal SITBs (i.e., "responders") after emotion awareness training will go straight to a four-week follow-up, and not receive cognitive reappraisal. Participants who evidence a less than satisfactory response in non-suicidal SITBs (i.e., "partial responders") after emotion awareness training will return to a two-week baseline phase before receiving cognitive reappraisal, and then enter a four-week follow-up. Participants who evidence little to no response in non-suicidal SITBs (i.e., "non-responders") after emotion awareness training will immediately receive cognitive reappraisal and then enter a four-week follow-up.

Behavioral: Emotion awareness training
Four weekly individual treatment sessions focused on increasing awareness of one's emotions.

Behavioral: Cognitive reappraisal
Four weekly individual treatment sessions focused on thinking about stimuli in a way that diminishes one's emotions.

Experimental: 4wk baseline + reappraisal + (awareness)

Participants in this arm will first undergo a four-week baseline phase. Participants who evidence a significant decrease in non-suicidal SITBs (i.e., "responders") after cognitive reappraisal will go straight to a four-week follow-up, and not receive emotion awareness training. Participants who evidence a less than satisfactory response in non-suicidal SITBs (i.e., "partial responders") after cognitive reappraisal will return to a two-week baseline phase before receiving emotion awareness training, and then enter a four-week follow-up. Participants who evidence little to no response in non-suicidal SITBs (i.e., "non-responders") after cognitive reappraisal will immediately receive emotion awareness training and then enter a four-week follow-up.

Behavioral: Emotion awareness training
Four weekly individual treatment sessions focused on increasing awareness of one's emotions.

Behavioral: Cognitive reappraisal
Four weekly individual treatment sessions focused on thinking about stimuli in a way that diminishes one's emotions.

Outcome Measures

Primary Outcome Measures

  1. Frequency of non-suicidal self-injurious thoughts and behaviors [Daily (up to 126 days)]

    Frequency of non-suicidal self-injurious thoughts and behaviors will be indicated by participants' responses to electronic questions delivered through a smart phone daily, assessed up to 126 days.

Secondary Outcome Measures

  1. Overall Anxiety Severity and Impairment Scale (OASIS) [Weekly (up to 18 weeks)]

  2. Overall Depression Severity and Impairment Scale (ODSIS) [Weekly (up to 18 weeks)]

  3. Beck Anxiety Inventory (BAI) [Weekly (up to 18 weeks)]

  4. Beck Depression Inventory (BDI-II) [Weekly (up to 18 weeks)]

  5. Deficits in Emotion Regulation Scale (DERS): Emotion Awareness and Nonacceptance of Negative Emotional Responses subscales [Weekly (up to 18 weeks)]

  6. Southampton Mindfulness Questionnaire (SMQ) [Weekly (up to 18 weeks)]

  7. Multi-dimensional Experiential Avoidance Questionnaire (MEAQ): Distraction/Suppression subscale [Weekly (up to 18 weeks)]

  8. Emotion Regulation Questionnaire (ERQ) [Weekly (up to 18 weeks)]

  9. Insomnia Severity Index (ISI) [Weekly (up to 18 weeks)]

    Only three items of the ISI are included.

  10. Subjective Symptoms Scale (SSS) [Weekly (up to 18 weeks)]

Other Outcome Measures

  1. Self-Injury Implicit Association Test (SI-IAT) [up to 18 weeks]

    The SI-IAT is a computerized behavioral test measures the implicit associations individuals hold about non-suicidal self-injury.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • At least 18 years old

  • Engage in non-suicidal self-injury (NSSI) to reduce or lessen negative thoughts or feelings

  • Not taking psychotropic medications, or meet criteria for stability on a particular dose and are willing to maintain a stable dosage throughout the study

  • Meet the proposed Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5) criteria for NSSI disorder, which includes:

  1. five or more days in which the individual has engaged in NSSI in the past year

  2. NSSI is associated with at least two two of the following: psychological precipitant (e.g., negative feelings or thoughts), urge prior to the act, preoccupation with NSSI, contingent response (e.g., expectation that the act will relieve a negative feeling state)

  3. clinically significant distress or interference caused by NSSI or its consequences

  4. NSSI does not occur exclusively during states of psychosis, delirium, or intoxication

  5. absence of suicidal intent

Exclusion Criteria:
  • Current suicidal ideation and intent

  • Currently receiving cognitive-behavioral therapy (CBT) or any psychotherapy to address NSSI, anxiety, depression, or other Axis I disorders (and are not willing to discontinue that treatment)

  • Unwilling to refrain from initiating additional treatment during the course of the study

  • Current or very recent symptoms that warrant immediate clinical attention, alternative treatment, and/or a higher level of care that cannot be provided through the study (e.g., florid delusions or hallucinations, rapid mood state, severe manic symptoms)

  • Current or recent (within 3 months) history of substance use disorder (exception would be marijuana, caffeine, nicotine)

  • Emotional symptomatology is due to a medical/physical condition

Contacts and Locations

Locations

Site City State Country Postal Code
1 Center for Anxiety and Related Disorders, Boston University Boston Massachusetts United States 02215

Sponsors and Collaborators

  • Boston University Charles River Campus
  • National Institute of Mental Health (NIMH)

Investigators

  • Principal Investigator: Kate H Bentley, M.A., Boston University
  • Principal Investigator: David H Barlow, Ph.D., Boston University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Kate H. Bentley, Doctoral Candidate, Boston University Charles River Campus
ClinicalTrials.gov Identifier:
NCT02060448
Other Study ID Numbers:
  • F31MH100761
  • F31MH100761
First Posted:
Feb 12, 2014
Last Update Posted:
Mar 21, 2017
Last Verified:
Mar 1, 2017
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Kate H. Bentley, Doctoral Candidate, Boston University Charles River Campus
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 21, 2017